Abstract:Diffuse large B-cell lymphoma (DLBCL) is the most common form of B-cell non-Hodgkin lymphoma (B-NHL) with significant morbidity and mortality despite advancements in treatment. Lymphoma and autoimmune disease both result from breakdowns in normal cell regulatory pathways, and epidemiological studies have confirmed both that B-NHL is more likely to develop in the setting of autoimmune diseases and vice versa. Red cell immunity, as evidenced by direct antiglobulin test (DAT) positivity, has been linked to DLBCL and more recently the pathogenic causes of this association have begun to be better understood using molecular techniques. This project aimed to explore the relationship between red cell autoimmunity and DLBCL. DAT positivity was more common in DLBCL as compared to healthy controls (20.4% vs 3.7%, p=0.0005). Univariate analysis found a non-significant trend towards poorer overall survival in the DAT positive (DAT+) compared to the DAT negative (DAT-) groups (p=0.087). High throughput sequencing was used to compare mutations in DLBCL from DAT+ and DAT- patients. The most frequently mutated genes in 15 patient samples were KMT2D (n=13), MYOM2 (n=9), EP300 (n=8), SPEN (n=7), and ADAMTSL3 (n=7), which were mutated in both DAT+ and DAT- groups. BIRC3 (n=3), FOXO1 (n=3) and CARD11 (n=2) were found to be mutated only in samples from the DAT+ group. These gene mutations may be involved in disease development and progression, and potentially represent targets for future therapy. The immunoglobulin genotype IGHV4-34 is seen more frequently in DLBCL clones than in normal B cells and has intrinsic autoreactivity to self-antigens on red cells, which is largely mediated by two motifs within the first framework region (FR1); Q6W7 and A24V25Y.26 These motifs form a hydrophobic patch which determines red cell antigen binding and are frequently mutated away from self-reactivity in normal B cells. If this does not occur this may provide constant B cell receptor signalling which encourages lymphoma development, a theory known as antigen driven lymphomagenesis. As with previous studies, IGHV4-34 was over-represented (15.6%) in our DLBCL cohort. Furthermore, of 6 IGHV4-34-expressing DLBCL samples five had unmutated hydrophobic patch mutations providing further evidence for antigen-driven lymphomagenesis. Mutation analysis of these five samples demonstrated high frequency of mutations in several genes, including CREBBP and NCOR2. Further research could explore if mutations in CREBBP and NCOR2 work in conjunction with the preserved QW and AVY motifs to promote lymphomagenesis in IGHV4-34-expressing B cells, and if so, could guide future targeted therapy.

Directing risky traffic in B cells with TNIP1

A TNIP1 -driven systemic autoimmune disorder with elevated IgG4

Human autoreactive T cells recognize CD1b and phospholipids

Heat shock protein gp96 regulates Toll-like receptor 9 proteolytic processing and conformational stability.

PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses

Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development

IRGM1 links mitochondrial quality control to autoimmunity

Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis

TNFAIP3 Overexpression Inhibits Diffuse Large B-Cell Lymphoma Progression by Promoting Autophagy through TLR4/MyD88/NF-κB Signaling Pathway

The ITPRIPL1- CD3ε Axis: a Novel Immune Checkpoint Controlling T Cells Activation

Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1

TNFAIP8L2/TIPE2 Impairs Autolysosome Reformation Via Modulating the RAC1-MTORC1 Axis.

Immunity-related GTPase IRGM at the intersection of autophagy, inflammation, and tumorigenesis

The signal regulatory protein gamma (SIRPγ) signaling constrains naïve CD8+ T cell activation with T1D risk associated polymorphisms leading to augmented T cell activation

Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help

TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity

Loss of RPA1 Impairs Peripheral T Cell Homeostasis and Exacerbates Inflammatory Damage Through Triggering T Cell Necroptosis

T-Cell Aging-Associated Phenotypes in Autoimmune Disease

Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology

B cell autophagy mediates TLR7-dependent autoimmunity and inflammation